The Trouble With Trials
24m
·
Inside the Breakthrough - How Science Comes to Life
·
Ten years ago, in a hospital in London England a drug company conducted a clinical trial. That trial went horribly wrong. The lessons learned from that event have informed every pharmaceutical trial since then. We will hear from one of the men who took that experimental drug.
We will also look to history -- and uncover the origin of the first ever clinical trial. It was conducted on a sailing ship in the middle of the ocean. The lessons learned from that experiment saved thousands of lives over the next century.
And lastly we will look at what SciMar is currently testing and consider the long ranging impact those trials might have.
These science stories from history help shed light on the modern research being done on Type 2 Diabetes. Specifically, we highlight the work of SciMar as they examine the hormone hepatalin and the effect it has on glucose levels in people who are living with type 2 diabetes. www.SciMar.ca
The episode The Trouble With Trials from the podcast Inside the Breakthrough - How Science Comes to Life has a duration of
24:22. It was first published
More episodes from Inside the Breakthrough - How Science Comes to Life
Spreading the News
Science communication has impacted our lives more than we ever thought it would. Getting complicated scientific and medical information out to a large number of people is crucial to our public health. And it is not easy.
We will look at how stories can help spread and preserve information. We start with the oldest true story ever told and ask why and how it stood the test of time.
Then we will listen to the most talked about radio play of all time: War of the Worlds. The lessons we can learn from that experience have so many layers, even if you think you know the story, you probably don’t.
Then we will talk to Gregory Brown, the host of ASAP Science.
He will explain what he thinks makes a great science story and how we can combat the global pandemic of misinformation and ‘science-phobia.’
These science stories from history help shed light on the modern research being done on Type 2 Diabetes. Specifically, we highlight the work of SciMar as they examine the hormone hepatalin and the effect it has on glucose levels in people who are living with type 2 diabetes. www.SciMar.ca
Guinea Pigs
Let’s talk about the use of animals in medical research. It’s not a subject that people are very comfortable discussing, but we are going to do it anyway.
We will start with an incredible story of a fire in Bar Harbor Maine that impacted the health of people all over the world for years, even though they never even knew about it.
Then we will ask the question ‘what really causes Ulcers, and how did researchers figure that out?’
Dr Wayne Lautt has used animals in his experiments for years. But his approach to it is very different from the mainstream view.
These science stories from history help shed light on the modern research being done on Type 2 Diabetes. Specifically, we highlight the work of SciMar as they examine the hormone hepatalin and the effect it has on glucose levels in people who are living with type 2 diabetes. www.SciMar.ca
Follow the Money
The relationship between researchers and funders is complicated.
Some people think that researchers should be left to their own direction and that all financial support should be ‘no-strings attached.’ But is that possible? Is it desirable?
We look at how the Roman Colosseum was funded, and ask ‘what impact did that have on its design and its use?’
Then we turn our attention to NASA --- is the space agency funded by the military? Should it be? And how has its unique funding arrangement impacted what it does?
Finally we’ll confront the thorny question of ‘how much influence should funding agencies have over research?’
We will speak with Rachelle Bruton, the Director of the National Programs Office at the National Research Council of Canada, and Rachael Maxwell, the Executive Director of Evidence for Democracy.
These science stories from history help shed light on the modern research being done on Type 2 Diabetes. Specifically, we highlight the work of SciMar as they examine the hormone hepatalin and the effect it has on glucose levels in people who are living with type 2 diabetes. www.SciMar.ca
Old Meets New
The Amish community in Pennsylvania is heavily impacted by genetic diseases. You might think that their resistance to modern technology would make it difficult to treat these conditions. But actually their philosophies around family and community make it easier to manage these diseases.
John Franklin’s ships were lost to the world for more than a century and a half. They were only discovered by a team of people that combined modern search tools with historical knowledge.
We talk with Jennefer Nepinak about the concept of ‘two-eyed seeing.” Through this approach we consider new ways of dealing with mental health, and diabetes.
These science stories from history help shed light on the modern research being done on Type 2 Diabetes. Specifically, we highlight the work of SciMar as they examine the hormone hepatalin and the effect it has on glucose levels in people who are living with type 2 diabetes. www.SciMar.ca
Too Much or Too Little?
We often complain about having too little of something: Too little time, too little money. But today in first world countries a lot of our problems come from having too much of something: Too much sugar, too much technology.
We point this lens at a pair of historical stories to better understand if tragedies and hardships of the past were really the result of having ‘too little’ of something, or if we need to use a different perspective.
We talk with Dr Jason Fung about his views on fasting and whether we eat too much, too little, or just too often!
These science stories from history help shed light on the modern research being done on Type 2 Diabetes. Specifically, we highlight the work of SciMar as they examine the hormone hepatalin and the effect it has on glucose levels in people who are living with type 2 diabetes. www.SciMar.ca